Loading...

Chia Tai Enterprises International Limited

3839.HKHKSE
Healthcare
Drug Manufacturers - Specialty & Generic
HK$4.86
HK$-0.31(-6.00%)

Chia Tai Enterprises International Limited (3839.HK) Stock Overview

Explore Chia Tai Enterprises International Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 66.9/100

Key Financials

Market Cap1.2B
P/E Ratio14.04
EPS (TTM)$0.35
ROE0.05%
Fundamental Analysis

AI Price Forecasts

1 Week$1.96
1 Month$1.66
3 Months$2.09
1 Year Target$1.03

3839.HK Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Chia Tai Enterprises International Limited (3839.HK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 69.00, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.03.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 14.04 and a market capitalization of 1.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Technical Indicators

69.00RSI (14)
0.90MACD
63.63ADX
Revenue Growth
76.89%
76.89%
Profit Growth
HK$0.04
337.45%
EPS Growth
HK$0.04
44.11%
Operating Margin
3.63%
429.51%
ROE
4.84%
337.45%
Dividend Yield
0.00%
Analyst Recommendations data is not available for 3839.HKAnalyst Recommendations details for 3839.HK are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Chia Tai Enterprises International Limited engages in the manufacture and sale of chlortetracycline (CTC) and other related products in Mainland China, the Asia Pacific, the Americas, Europe, and internationally. It operates through two segments, Biochemical and Industrial. The Biochemical segment manufactures and sells CTC premix and CTC hydrochloride products, which are used as feed additives to promote growth of livestock, prevent or cure animal diseases, and enhance feed efficiency under the Shihao and Citifac brands. The Industrial segment engages in the sale, leasing, and servicing of caterpillar machinery equipment, including excavators, power generators, bulldozers, and compactors, as well as spare parts; and manufacture and sale of carburetors and automotive parts for automobile and motorcycle manufacturers. The company was incorporated in 1987 and is based in Central, Hong Kong. Chia Tai Enterprises International Limited is a subsidiary of Charoen Pokphand Foods Public Company Limited.

CEO

Thirayut Phityaisarakul

Employees

900

Headquarters

Far East Finance Centre, Central

Founded

2015

Frequently Asked Questions

;